Revenue
attach_money638M USD
YoY +65.5%
AXSMAxsome Therapeutics, Inc.$ --
Axsome Therapeutics, Inc.
AXSM
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-169M USD
YoY +39.7%
Net Income
verified-183M USD
YoY +36.2%
EPS
pie_chart-3.68USD
YoY +38.6%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress137.8%On Track
Revenue Progress191.2M
Revenue Forecast987.9M
Net Income Progress-64.5M
Net Income Forecast-46.8M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.